Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Jun 22, 2018 8:11am

148 Views

Post# 28211186

RE:RE:RE:Denis Boucher bought convertible notes

I think you’re splitting hairs.

Any further invest,net by management in TH from their own $$$ is a bullish sign.

No need to overthink it.

bfw

palinc2000 wrote: Insiders and investors have two options

1- For greater return if they think the SP will be close to 19.35 or higher within 3 years then buying the stock now is a better option
2- However if you are prepared to miss the next 6 dollrs increase in the SP im exchange for a 5.75 % yearly interest rate then you buy the convert

So insiders buying the convert is not as good a sign but still shows confidence.
On the other hand Luc is probably already over invested .So an additional 100k of personal fund is nice to see